Skip to main content
International Flavors & Fragrances Inc (IFF)
Chemicals Basic Materials
Stock AI

IFF Launches Tender Offers for Outstanding Notes Worth Up to $1.8 Billion

Last updated: May 02, 2025
Taurigo

International Flavors & Fragrances Inc. (IFF), a leading player in the flavors and fragrances industry, has announced a strategic move to optimize its capital structure through the commencement of tender offers for certain outstanding series of notes. This initiative, revealed in a press release on May 2, 2025, could see IFF repurchasing notes for an aggregate purchase price of up to $1.8 billion, excluding accrued and unpaid interest.

1. Overview of the Tender Offers

IFF's tender offers are split into two pools, with a maximum purchase price of $1.0 billion for Pool 1 and $800 million for Pool 2. The company aims to streamline its financial obligations while capitalizing on favorable market conditions.

Pool 1 Tender Offers

The first pool consists of the following securities:

Title of Security CUSIP/ISIN Principal Amount Outstanding (in millions) Acceptance Priority Level Series Tender Cap U.S. Treasury Reference Security Bloomberg Reference Page Fixed Spread Early Tender Payment
1.230% Senior Notes due 2025 459506AN1 $1,000 1 $500 million 5.000% UST due 9/30/25 FIT3 + 0 bps $30
1.832% Senior Notes due 2027 459506AP6 $1,200 2 $300 million 3.750% UST due 4/30/27 FIT1 + 75 bps $30
2.300% Senior Notes due 2030 459506AQ4 $1,500 3 N/A 3.875% UST due 4/30/30 FIT1 + 110 bps $30
4.450% Senior Notes due 2028 459506AK7 $400 4 N/A 3.750% UST due 4/15/28 FIT1 + 95 bps $30

Pool 2 Tender Offers

The second pool features:

Title of Security CUSIP/ISIN Principal Amount Outstanding (in millions) Acceptance Priority Level Series Tender Cap U.S. Treasury Reference Security Bloomberg Reference Page Fixed Spread Early Tender Payment
3.468% Senior Notes due 2050 459506AS0 $1,500 1 $600 million 4.500% UST due 11/15/54 FIT1 + 135 bps $30
3.268% Senior Notes due 2040 459506AR2 $750 2 $450 million 4.625% UST due 2/15/35 FIT1 + 165 bps $30
4.375% Senior Notes due 2047 459506AE1 $500 3 N/A 4.750% UST due 2/15/45 FIT1 + 145 bps $30
5.000% Senior Notes due 2048 459506AL5 $800 4 N/A 4.750% UST due 2/15/45 FIT1 + 140 bps $30

2. Funding the Tender Offers

The proceeds from IFF's recent sale of its Pharma Solutions business, completed on May 1, 2025, will finance the purchase of the validly tendered and accepted notes. This divestiture aligns with the company’s strategic focus on enhancing its core operations and reallocating capital towards growth initiatives.

3. Tender Offer Timeline

The tender offers will expire at 5:00 p.m. New York City time on June 2, 2025, unless extended or terminated earlier. For holders who wish to take advantage of the Early Tender Payment, valid tenders must be submitted by May 15, 2025. The total consideration for each series of notes will be determined based on fixed spreads and U.S. Treasury reference yields as of May 16, 2025.

4. Strategic Implications

This tender offer represents a proactive step for IFF in managing its debt profile and enhancing financial flexibility. By reducing outstanding notes, the company aims to lower interest expenses and improve its balance sheet metrics, positioning itself for future growth opportunities.

As IFF navigates these financial maneuvers, it remains committed to delivering value to its shareholders while maintaining a strong focus on innovation within the flavors and fragrances sector. The outcome of these tender offers will be closely monitored by investors and market analysts alike, as it reflects IFF's strategic adjustments in a competitive landscape.

You may also be interested in:
Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.